Sonoma Bio Raises $265m To Test T-regs In Autoimmune Diseases

First Indication Is RA, But IBD Is Another Opportunity

 
• By Mandy Jackson
  
Young woman with rheumatoid arthritis deformed fingers
Sonoma Bio's T-reg therapies may offer a polypharmacy approach to treating rheumatoid arthritis and other autoimmune diseases • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business